Pulmonary impairment after tuberculosis and its contribution to TB burden
- PMID: 20482835
- PMCID: PMC2894771
- DOI: 10.1186/1471-2458-10-259
Pulmonary impairment after tuberculosis and its contribution to TB burden
Abstract
Background: The health impacts of pulmonary impairment after tuberculosis (TB) treatment have not been included in assessments of TB burden. Therefore, previous global and national TB burden estimates do not reflect the full consequences of surviving TB. We assessed the burden of TB including pulmonary impairment after tuberculosis in Tarrant County, Texas using Disability-adjusted Life Years (DALYs).
Methods: TB burden was calculated for all culture-confirmed TB patients treated at Tarrant County Public Health between January 2005 and December 2006 using identical methods and life tables as the Global Burden of Disease Study. Years of life-lost were calculated as the difference between life expectancy using standardized life tables and age-at-death from TB. Years lived-with-disability were calculated from age and gender-specific TB disease incidence using published disability weights. Non-fatal health impacts of TB were divided into years lived-with-disability-acute and years lived-with-disability-chronic. Years lived-with-disability-acute was defined as TB burden resulting from illness prior to completion of treatment including the burden from treatment-related side effects. Years lived-with-disability-chronic was defined as TB burden from disability resulting from pulmonary impairment after tuberculosis.
Results: There were 224 TB cases in the time period, of these 177 were culture confirmed. These 177 subjects lost a total of 1189 DALYs. Of these 1189 DALYs 23% were from years of life-lost, 2% were from years lived-with-disability-acute and 75% were from years lived-with-disability-chronic.
Conclusions: Our findings demonstrate that the disease burden from TB is greater than previously estimated. Pulmonary impairment after tuberculosis was responsible for the majority of the burden. These data demonstrate that successful TB control efforts may reduce the health burden more than previously recognized.
Figures




Similar articles
-
The burden of tuberculosis and attributable risk factors in Brazil, 1990-2017: results from the Global Burden of Disease Study 2017.Popul Health Metr. 2020 Sep 30;18(Suppl 1):10. doi: 10.1186/s12963-020-00203-6. Popul Health Metr. 2020. PMID: 32993691 Free PMC article.
-
The societal cost of tuberculosis: Tarrant County, Texas, 2002.Ann Epidemiol. 2010 Jan;20(1):1-7. doi: 10.1016/j.annepidem.2009.09.004. Ann Epidemiol. 2010. PMID: 20006270
-
Disease burden of tuberculosis and post-tuberculosis in Inner Mongolia, China, 2016-2018 - based on the disease burden of post-TB caused by COPD.BMC Infect Dis. 2023 Jun 14;23(1):406. doi: 10.1186/s12879-023-08375-w. BMC Infect Dis. 2023. PMID: 37316793 Free PMC article.
-
Rethinking Tuberculosis Morbidity Quantification: A Systematic Review and Critical Appraisal of TB Disability Weights in Cost-Effectiveness Analyses.Pharmacoeconomics. 2024 Nov;42(11):1209-1236. doi: 10.1007/s40273-024-01410-x. Epub 2024 Aug 7. Pharmacoeconomics. 2024. PMID: 39110388 Free PMC article.
-
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.Lancet. 2013 Nov 9;382(9904):1575-86. doi: 10.1016/S0140-6736(13)61611-6. Epub 2013 Aug 29. Lancet. 2013. PMID: 23993280 Review.
Cited by
-
Respiratory symptoms and health-related quality of life in post-tuberculosis subjects with physician-diagnosed bronchiectasis: a cross-sectional study.J Thorac Dis. 2021 Aug;13(8):4894-4902. doi: 10.21037/jtd-20-3028. J Thorac Dis. 2021. PMID: 34527328 Free PMC article.
-
Rapamycin modulates pulmonary pathology in a murine model of Mycobacterium tuberculosis infection.Dis Model Mech. 2021 Oct 1;14(10):dmm049018. doi: 10.1242/dmm.049018. Epub 2021 Oct 26. Dis Model Mech. 2021. PMID: 34486033 Free PMC article.
-
A prospective longitudinal study of chronic pulmonary aspergillosis in pulmonary tuberculosis in Indonesia (APICAL).Thorax. 2022 Aug;77(8):821-828. doi: 10.1136/thoraxjnl-2020-216464. Epub 2021 Nov 30. Thorax. 2022. PMID: 34848556 Free PMC article.
-
TB morbidity estimates overlook the contribution of post-TB disability: evidence from urban Malawi.BMJ Glob Health. 2022 May;7(5):e007643. doi: 10.1136/bmjgh-2021-007643. BMJ Glob Health. 2022. PMID: 35606014 Free PMC article.
-
Rheumatic heart disease: infectious disease origin, chronic care approach.BMC Health Serv Res. 2017 Nov 29;17(1):793. doi: 10.1186/s12913-017-2747-5. BMC Health Serv Res. 2017. PMID: 29187184 Free PMC article. Review.
References
-
- World Health Organization. Geneva: WHO. Estimated incidence, prevalence and TB mortality; 2004. http://www.who.int/mediacentre/factsheets/fs104/en/ [homepage on the internet]. [one screen].
-
- CDC Reported Tuberculosis in the United States (2003) Reported Tuberculosis in the United States, 2003. Tuberculosis Case Rates and Death Rates United States, 1953-2003. U. S. Department of Health and Human Services. Centers for Disease Control and Prevention; 2004. Atlanta, GA. 50 Years of TB Surveillance.http://www.cdc.gov/nchstp/tb/
-
- The World health report 2000. health systems: improving performance. ISBN 92 4 156198 X NLM Classification: WA 540.1. World Health Organization. Geneva;
-
- Jamison DT, Breman JG, Measham AR. Diseases Control Priorities in Developing Countries. 2. Oxford University Press & the World Bank; pp. 3–35. ISBN-10-0-8213-0821361791. 289-311. - PubMed
-
- Sodeman WA, Sodeman TM, eds. Pathologic physiology: mechanisms of disease. 7. Philadelphia: PA. W.B. Saunders Company; 1985. pp. 467–8.
MeSH terms
LinkOut - more resources
Full Text Sources